AKT1 and esophageal squamous cell carcinoma: FGF-2, by binding to FGFR 1–4, mediates the activation of numerous cell signaling pathways, including MAPK/ERK and PI3K-AKT-mTOR, thus sustaining survival and promoting the proliferation of ESCC [69].